查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439343

全球玻璃体视网膜手术器械市场：洞察、竞争格局、市场预测：2030 年

Vitreoretinal Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2023年全球玻璃体视网膜手术设备市场规模为16.8亿美元。预计到 2030 年，该市场将达到 26.2 亿美元，2024 年至 2030 年的预测期间复合年增长率为 7.69%。对玻璃体视网膜手术设备的需求主要是由于视网膜剥离、黄斑部病变、糖尿病视网膜病变和视网膜前膜等眼部疾病盛行率的上升所推动的。此外，老年人口的增加、糖尿病等生活方式相关疾病盛行率的上升、产品开发的技术创新以及微创手术适应性的提高将在预测期内推动玻璃体视网膜手术产品的需求。中国玻璃体视网膜手术设备市场的成长。

由于各种原因，玻璃体视网膜手术设备市场的产品需求正在成长，但主要原因之一是全球视力障碍盛行率的上升。这些设备正在帮助接受视力障碍治疗和管理的人们改善视力。

根据世界卫生组织 (WHO) 2022 年的报告，至少有 22 亿人患有近视或远视。其中至少有 10 亿人（几乎一半）患有视力丧失，且这种情况在全球范围内尚未得到预防或解决。根据同一份文件，视力障碍和失明的主要原因是未矫正的屈光不正和白内障。

此外，虽然大多数视力丧失和失明的人都在 50 岁以上，但根据世界卫生组织 (WHO) 2022 年的数据，视力丧失可能影响所有年龄层的人。因此，全球老年人口的增加也是推动玻璃体视网膜手术器械市场成长的因素。

该报告研究了全球玻璃体视网膜手术器械市场，并提供了市场概述，包括按类型、产品类型、最终用户、地区和参与市场的公司概况划分的趋势。

目录

第一章玻璃体视网膜手术器械市场报告简介

第二章玻璃体视网膜手术器械市场执行摘要

第三章 法规与专利分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章玻璃体视网膜手术器械市场主要因素分析

  • 玻璃体视网膜手术设备市场的驱动因素
  • 玻璃体视网膜手术器械市场的抑制因素与挑战
  • 玻璃体视网膜手术器械市场的机会

第五章玻璃体视网膜手术器械市场的波特五力分析

第六章 COVID-19对玻璃体视网膜手术器械市场的影响分析

第七章 玻璃体视网膜手术器械市场概况

  • 按类型
  • 按产品类型
  • 按最终用户
  • 按地区

第八章玻璃体视网膜手术器械市场全球公司份额分析－3至5家主要公司

第九章玻璃体视网膜手术器械市场公司及产品概况

  • Bausch & Lomb Incorporated
  • Alcon Inc.
  • Dutch Ophthalmic Research Center (International) B.V.
  • OCULUS Optikgerate GmbH
  • Paragon Care Group Australia Pty Ltd.
  • MedOne Surgical, Inc.
  • Zeiss Group
  • Geuder AG
  • Topcon Corporation
  • IRIDEX Corporation
  • Ellex Medical Lasers
  • Quantel Medical
  • MEDA Co., Ltd.
  • Lumenis
  • NIDEK CO., LTD.
  • Lightmed Corporation
  • Oertli Instrumente AG
  • BVI Medical
  • Johnson &Johnson Vision
  • OPTIKON

第10章 KOL观点

第十一章专案方法

第 12 章. 关于 DelveInsight

第十三章 免责声明与联络我们

Product Code: DIMDCL0135

Vitreoretinal Surgery Devices Market By Type (Surgical Packs, Systems, Accessories, And Disposables), By Product Type (Photocoagulation Surgery Devices, Vitrectomy Systems, Illumination Surgery Devices, Vitreoretinal Prefilled Silicone Oil Syringes, Others), By End-User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centres), by geography is expected to grow at a steady CAGR (forecast period - 2024-2030) owing to the rising prevalence of eye diseases and growing geriatric population base

Global Vitreoretinal Surgery Devices Market was valued at USD 1.68 billion in 2023, growing at a CAGR of 7.69% during the forecast period from 2024 to 2030 to reach USD 2.62 billion by 2030. The demand for Vitreoretinal Surgery Devices is primarily being boosted by the rising prevalence of eye diseases like retinal detachment, macular degeneration, diabetic retinopathy, and epiretinal membrane. Moreover, the rising geriatric population base, growing prevalence of lifestyle disorders such as diabetes, technical innovations in product development, and growing adaptability of less invasive procedures are expected to drive the vitreoretinal surgery product demand thereby contributing to the growth of the Vitreoretinal Surgery Devices market during the forecast period.

Vitreoretinal Surgery Devices Market Dynamics:

The Vitreoretinal Surgery Devices market is witnessing a growth in product demand owing to various reasons, one of the major reasons is the rising prevalence of vision impairment globally. These devices help in the improvement of visual fields of people suffering from Treatment and management of visual impairment.

As per World Health Organization 2022, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion - or almost half - of these cases, vision impairment could have been prevented or has yet to be addressed globally. As per the same source, the leading causes of vision impairment and blindness are uncorrected refractive errors and cataracts.

According to the Association for Research in Vision and Ophthalmology 2022, worldwide, an estimated 1.84 million people aged 50+ years were blind due to AMD, and a further 6.22 million were moderately or severely vision impaired (MSVI) in 2020.

Moreover, as per World Health Organization, 2022 data, the majority of people with vision impairment and blindness are over the age of 50 years; however, vision loss can affect people of all ages. Therefore, the increasing geriatric population base across the globe is another factor propelling the growth of the Vitreoretinal Surgery Devices market. According to the data provided by the World Health Organization, in 2020, about one billion people across the world were over the age of 60. The source further stated that by 2050, the elderly population in the 60 and above age group is expected to double in number representing about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million. Age is considered as one of the key risk factors associated with the progression of eye diseases, therefore, the rising elderly population is expected to lead to the rise in the patient population of vitreoretinal surgery across the world, which in turn would lead to an increase in demand for Vitreoretinal Surgery Devices during the forecast period, which will drive the global Vitreoretinal Surgery Devices market growth.

Moreover, technological advancements in product development and related product approvals by the government are another key factor that is responsible for the growth of the Global Vitreoretinal Surgery Devices market. For instance, in July 2019 Bausch + Lomb announced the launch of the FreeFlow infusion system for retina surgery and the 23-gauge Bi-Blade dual-port vitrectomy cutter for the Stellaris Elite vision enhancement system. This kind of development provides the surgeons with great control during their high flow vitrectomy procedures. Such technological advancements are expected to contribute to the Vitreoretinal Surgery Devices market.

Further, the outbreak of the COVID-19 pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospital procedures. This resulted in the reduced number of routine clinical examinations of the ophthalmic and related procedures. However, vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits, thereby bringing the demand for products on track in the Vitreoretinal Surgery Devices market.

However, postoperative complications associated with Vitreoretinal Surgery Devices and retinal toxicity of medical devices used during Vitreoretinal Surgery may be certain impeding factors to Vitreoretinal Surgery Devices market growth.

Vitreoretinal Surgery Devices Market Segment Analysis:

Vitreoretinal Surgery Devices Market By Type (Surgical Packs, Systems, Accessories, and Disposables), By Product Type (Photocoagulation Surgery Devices, Vitrectomy Systems, Illumination Surgery Devices, Vitreoretinal Prefilled Silicone Oil Syringes, Others), By End-User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centres), By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type segment of the Vitreoretinal Surgery Devices Market, the Systems are expected to hold a significant share during the forecast period. This can be ascribed to the fact that these are being more preferred by end-users over conventional Vitreoretinal Surgery Devices because these devices have now been redesigned and come integrated with laser control functions and greater light output.

Furthermore, the major players are also marketing advantageous products such as an ultra-short vitrectomy kit that includes a trocar/cannula that is shorter, and stiffer, and a light pipe that is brighter, which ultimately eases the process during surgery. Also, these innovations allow the real-time display of parameters on the monitor. Therefore, the advantages offered by the Systems are predicted to aid in the growth of the Vitreoretinal Surgery Devices market during the forecast period.

North America is expected to dominate the overall Vitreoretinal Surgery Devices Market:

Among all the regions, North America is expected to account for the largest share in the Vitreoretinal Surgery Devices market. Owing to significant growth factors such as the increasing prevalence of eye diseases, rising prevalence of the geriatric population, rising cases of diabetes that leads to eye disorders, and rising government initiatives for creating awareness regarding less invasive procedures are expected to aid in the growth of North America Vitreoretinal Surgery Devices Market.

As per BrightFocus Foundation 2022, as many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. Moreover, Macular degeneration is a leading cause of vision loss in Americans 60 years of age and older. Thus, the burgeoning cases of ophthalmic conditions and eye surgeries will contribute to the Global Vitreoretinal Surgery Devices Market growth that may, in turn, drive the demand for Vitreoretinal Surgery Devices in the forecast period.

In addition, as per the National Diabetics Statistics Report published by the Centers for Disease Control and Prevention (CDC) in 2020, about 34.2 million Americans were diabetic 2020. As per the CDC itself, diabetes is considered one of the major risk factors that may lead to diabetic retinopathy development and progression over time, as increased blood sugar results in amplified eye pressure which in turn upsurges the damage of the retina in the eye. With the high presence of the diabetic population in the country, it is estimated that there may be an increase in the diabetic retinopathy patient population that may, in turn, drive the demand for Vitreoretinal Surgery Devices in the forecast period.

Along with the factors mentioned above, the conducive environment for product development and launches in the country further motivates the market players to enhance their presence in North America. Moreover, efforts such as the conducting of local clinical trials to establish product safety and efficacy help in the faster device approval by the concerned local authorities and speed up the market approval process for the devices.

Therefore, the aforementioned factors all will collectively contribute towards the growing regional demand for such devices thereby driving the Vitreoretinal Surgery Devices market during the forecast period.

Vitreoretinal Surgery Devices Market Key Players:

Some of the key market players operating in the Vitreoretinal Surgery Devices market include Bausch & Lomb Incorporated, Alcon Inc., Dutch Ophthalmic Research Center (International) B.V., OCULUS Optikgerate GmbH, Paragon Care Group Australia Pty Ltd., MedOne Surgical, Inc., Zeiss Group, Geuder AG, Topcon Corporation, IRIDEX Corporation, Ellex Medical Lasers, Quantel Medical, MEDA Co., Ltd., Lumenis, NIDEK CO., LTD., Lightmed Corporation, Oertli Instrumente AG, BVI Medical, Johnson & Johnson Vision, OPTIKON, among others.

Recent Developmental Activities in the Vitreoretinal Surgery Devices Market:

In July 2022, Aldeyra Therapeutics, Inc. announced the US Food and Drug Administration (FDA) orphan drug designation for ADX-2191 (methotrexate for intravitreal injection) for the treatment of primary vitreoretinal lymphoma (PVRL).

In June 2019, ZEISS India introduced FCI Vitreoretinal surgical devices in India. The FCI products were made available through an exclusive partnership between ZEISS India and FCI (France Chirurgie Instrumentation) S.A.S. This partnership offered the end-users a wide variety of options, which contributed to the growth of the Vitreoretinal Surgery Devices Market.

In December 2019, BVI Medical acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicone oils, gases, and perfluorocarbons used in vitreoretinal surgery. Growth in the Vitreoretinal Surgery Devices Market will be accelerated through the broad-reaching commercial infrastructure of BVI established with the Vitreq line of vitreoretinal surgical products.

Key Takeaways from the Vitreoretinal Surgery Devices Market Report Study

Market size analysis for current Vitreoretinal Surgery Devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Vitreoretinal Surgery Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Vitreoretinal Surgery Devices Market.

Various opportunities available for the other competitor in the Vitreoretinal Surgery Devices Market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Vitreoretinal Surgery Devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Vitreoretinal Surgery Devices market growth in the coming future?

Target Audience who can be benefited from this Vitreoretinal Surgery Devices Market Report Study

Vitreoretinal Surgery Devices products providers

Research organizations and consulting companies

Vitreoretinal Surgery Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Vitreoretinal Surgery Devices

Various End-users who want to know more about the Vitreoretinal Surgery Devices market and latest technological developments in the Vitreoretinal Surgery Devices market.

Frequently Asked Questions for Vitreoretinal Surgery Devices Market:

1. What is a Vitreoretinal Surgery Device?

Vitreoretinal surgery is done to treat the retina, macula, and vitreous fluid-associated eye diseases. These include macular degeneration, retinal detachment, vitreous hemorrhage and uveitis, macular void, epiretinal membrane, retinal detachment, and diabetic retinopathy-associated complications. These are different types of devices with varied applications during vitreoretinal surgery.

2. What is the market for Global Vitreoretinal Surgery Devices?

Global Vitreoretinal Surgery Devices Market was valued at USD 1.68 billion in 2023, growing at a CAGR of 7.69% during the forecast period from 2024 to 2030 to reach USD 2.62 billion by 2030.

3. What are the drivers for Global Vitreoretinal Surgery Devices Market?

The demand for Vitreoretinal Surgery Devices is primarily being boosted by the rising prevalence of eye diseases, the rising geriatric population base, growing prevalence of lifestyle disorders such as diabetes and technical innovation in product development, and adaptability of less invasive procedures are expected to drive the product demand thereby contributing to the growth of the Vitreoretinal Surgery Devices market in the forecast period.

4. Who are the key players operating in Global Vitreoretinal Surgery Devices Market?

Some of the key market players operating in the Vitreoretinal Surgery Devices market include Bausch & Lomb Incorporated, Alcon Inc., Dutch Ophthalmic Research Center (International) B.V., OCULUS Optikgerate GmbH, Paragon Care Group Australia Pty Ltd., MedOne Surgical, Inc., Zeiss Group, Geuder AG, Topcon Corporation, IRIDEX Corporation, Ellex Medical Lasers, Quantel Medical, MEDA Co., Ltd., Lumenis, NIDEK CO., LTD., Lightmed Corporation, Oertli Instrumente AG, BVI Medical, Johnson & Johnson Vision, OPTIKON, and others.

5. Which region has the highest share in Vitreoretinal Surgery Devices market?

North America is expected to dominate the overall Vitreoretinal Surgery Devices market during the forecast period, 2024 to 2030. Owing to significant growth factors such as the increasing prevalence of eye diseases, rising prevalence of the geriatric population, rising cases of diabetes that leads to eye disorders, and rising government initiatives for creating awareness regarding less invasive procedures in this region.

Table of Contents

1.Vitreoretinal Surgery Devices Market Report Introduction

2.Vitreoretinal Surgery Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Vitreoretinal Surgery Devices Market Key Factors Analysis

  • 4.1. Vitreoretinal Surgery Devices Market Drivers
    • 4.1.1. Rising Prevalence of eye diseases
    • 4.1.2. Growing Geriatric Population Base
    • 4.1.3. Growing adaptability of less invasive procedures
    • 4.1.4. Technical Innovation in Product Development
  • 4.2. Vitreoretinal Surgery Devices Market Restraints and Challenges
    • 4.2.1. Postoperative complications associated with Vitreoretinal Surgery Devices
    • 4.2.2. Retinal Toxicity of Medical Devices used during Vitreoretinal Surgery
  • 4.3. Vitreoretinal Surgery Devices Market Opportunities
    • 4.3.1. Need for Safe and Less Complicated Devices

5. Vitreoretinal Surgery Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vitreoretinal Surgery Devices Market

7. Vitreoretinal Surgery Devices Market Layout

  • 7.1. By Type
    • 7.1.1. Surgical Packs
    • 7.1.2. Systems
    • 7.1.3. Accessories
    • 7.1.4. Disposables
  • 7.2. By Product Type
    • 7.2.1. Photocoagulation Surgery Devices
    • 7.2.2. Vitrectomy Systems
    • 7.2.3. Illumination Surgery Devices
    • 7.2.4. Vitreoretinal Prefilled Silicone Oil Syringes
    • 7.2.5. Others
  • 7.3. By End User
    • 7.3.1. Hospitals
    • 7.3.2. Ophthalmology Clinics
    • 7.3.3. Ambulatory Surgical Centers
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States
      • 7.4.1.2. Canada
      • 7.4.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. France
      • 7.4.2.2. Germany
      • 7.4.2.3. United Kingdom
      • 7.4.2.4. Italy
      • 7.4.2.5. Spain
      • 7.4.2.6. Russia
      • 7.4.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China
      • 7.4.3.2. Japan
      • 7.4.3.3. India
      • 7.4.3.4. Australia
      • 7.4.3.5. South Korea
      • 7.4.3.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East
      • 7.4.4.2. Africa
      • 7.4.4.3. South America

8. Vitreoretinal Surgery Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Vitreoretinal Surgery Devices Market Company and Product Profiles

  • 9.1. Bausch & Lomb Incorporated
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Alcon Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Dutch Ophthalmic Research Center (International) B.V.
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. OCULUS Optikgerate GmbH
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Paragon Care Group Australia Pty Ltd.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. MedOne Surgical, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Zeiss Group
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Geuder AG
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Topcon Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. IRIDEX Corporation
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Ellex Medical Lasers
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Quantel Medical
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. MEDA Co., Ltd.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Lumenis
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. NIDEK CO., LTD.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Lightmed Corporation
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Oertli Instrumente AG
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. BVI Medical
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Johnson & Johnson Vision
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. OPTIKON
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Vitreoretinal Surgery Devices Market in Global (2021-2030)
  • Table 4: Vitreoretinal Surgery Devices Market in Global by Type (2021-2030)
  • Table 5: Vitreoretinal Surgery Devices Market in Global by Product Type (2021-2030)
  • Table 6: Vitreoretinal Surgery Devices Market in Global by End User (2021-2030)
  • Table 7: Vitreoretinal Surgery Devices Market in Global by Geography (2021-2030)
  • Table 8: Vitreoretinal Surgery Devices Market in North America (2021-2030)
  • Table 9: Vitreoretinal Surgery Devices Market in North America by Country (2021-2030)
  • Table 10: Vitreoretinal Surgery Devices Market in the US (2021-2030)
  • Table 11: Vitreoretinal Surgery Devices Market in Canada (2021-2030)
  • Table 12: Vitreoretinal Surgery Devices Market in Mexico (2021-2030)
  • Table 13: Vitreoretinal Surgery Devices Market in Europe (2021-2030)
  • Table 14: Vitreoretinal Surgery Devices Market in Europe by Country (2021-2030)
  • Table 15: Vitreoretinal Surgery Devices Market in France (2021-2030)
  • Table 16: Vitreoretinal Surgery Devices Market in Germany (2021-2030)
  • Table 17: Vitreoretinal Surgery Devices Market in the United Kingdom (2021-2030)
  • Table 18: Vitreoretinal Surgery Devices Market in Italy (2021-2030)
  • Table 19: Vitreoretinal Surgery Devices Market in Spain (2021-2030)
  • Table 20: Vitreoretinal Surgery Devices Market in Russia (2021-2030)
  • Table 21: Vitreoretinal Surgery Devices Market in Rest of Europe (2021-2030)
  • Table 22: Vitreoretinal Surgery Devices Market in APAC (2021-2030)
  • Table 23: Vitreoretinal Surgery Devices Market in APAC by Country (2021-2030)
  • Table 24: Vitreoretinal Surgery Devices Market in China (2021-2030)
  • Table 25: Vitreoretinal Surgery Devices Market in Japan (2021-2030)
  • Table 26: Vitreoretinal Surgery Devices Market in India (2021-2030)
  • Table 27: Vitreoretinal Surgery Devices Market in Australia (2021-2030)
  • Table 28: Vitreoretinal Surgery Devices Market in South Korea (2021-2030)
  • Table 29: Vitreoretinal Surgery Devices Market in Rest of APAC (2021-2030)
  • Table 30: Vitreoretinal Surgery Devices Market in Rest of World (2021-2030)
  • Table 31: Vitreoretinal Surgery Devices Market in RoW by Region (2021-2030)
  • Table 32: Vitreoretinal Surgery Devices Market in Middle East (2021-2030)
  • Table 33: Vitreoretinal Surgery Devices Market in Africa (2021-2030)
  • Table 34: Vitreoretinal Surgery Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Vitreoretinal Surgery Devices Market in Global (2021-2030)
  • Figure 4: Vitreoretinal Surgery Devices Market in Global by Type (2021-2030)
  • Figure 5: Vitreoretinal Surgery Devices Market in Global by Product Type (2021-2030)
  • Figure 6: Vitreoretinal Surgery Devices Market in Global by End User (2021-2030)
  • Figure 7: Vitreoretinal Surgery Devices Market in Global by Geography (2021-2030)
  • Figure 8: Vitreoretinal Surgery Devices Market in North America (2021-2030)
  • Figure 9: Vitreoretinal Surgery Devices Market in North America by Country (2021-2030)
  • Figure 10: Vitreoretinal Surgery Devices Market in the US (2021-2030)
  • Figure 11: Vitreoretinal Surgery Devices Market in Canada (2021-2030)
  • Figure 12: Vitreoretinal Surgery Devices Market in Mexico (2021-2030)
  • Figure 13: Vitreoretinal Surgery Devices Market in Europe (2021-2030)
  • Figure 14: Vitreoretinal Surgery Devices Market in Europe by Country (2021-2030)
  • Figure 15: Vitreoretinal Surgery Devices Market in France (2021-2030)
  • Figure 16: Vitreoretinal Surgery Devices Market in Germany (2021-2030)
  • Figure 17: Vitreoretinal Surgery Devices Market in the United Kingdom (2021-2030)
  • Figure 18: Vitreoretinal Surgery Devices Market in Italy (2021-2030)
  • Figure 19: Vitreoretinal Surgery Devices Market in Spain (2021-2030)
  • Figure 20: Vitreoretinal Surgery Devices Market in Russia (2021-2030)
  • Figure 21: Vitreoretinal Surgery Devices Market in Rest of Europe (2021-2030)
  • Figure 22: Vitreoretinal Surgery Devices Market in APAC (2021-2030)
  • Figure 23: Vitreoretinal Surgery Devices Market in APAC by Country (2021-2030)
  • Figure 24: Vitreoretinal Surgery Devices Market in China (2021-2030)
  • Figure 25: Vitreoretinal Surgery Devices Market in Japan (2021-2030)
  • Figure 26: Vitreoretinal Surgery Devices Market in India (2021-2030)
  • Figure 27: Vitreoretinal Surgery Devices Market in Australia (2021-2030)
  • Figure 28: Vitreoretinal Surgery Devices Market in South Korea (2021-2030)
  • Figure 29: Vitreoretinal Surgery Devices Market in Rest of APAC (2021-2030)
  • Figure 30: Vitreoretinal Surgery Devices Market in Rest of World (2021-2030)
  • Figure 31: Vitreoretinal Surgery Devices Market in RoW by Region (2021-2030)
  • Figure 32: Vitreoretinal Surgery Devices Market in Middle East (2021-2030)
  • Figure 33: Vitreoretinal Surgery Devices Market in Africa (2021-2030)
  • Figure 34: Vitreoretinal Surgery Devices Market in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis